Limits...
N-(4-Bromo-phen-yl)-2-[(1-cyclo-hexyl-meth-yl-1H-1,2,4-triazol-3-yl)sulfanyl]-acetamide.

Wang YP, Yan WL, Guo Q, He YP - Acta Crystallogr Sect E Struct Rep Online (2012)

Bottom Line: In the molecule, there is an N-H⋯S hydrogen bond making a five-membered ring.In the crystal, mol-ecules are connected into centrosymmetric dimers via pairs of N-H⋯N and weak C-H⋯N hydrogen bonds.The crystal structure also features C-H⋯O inter-actions.

View Article: PubMed Central - HTML - PubMed

ABSTRACT
The title compound, C(17)H(21)BrN(4)OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N-H⋯S hydrogen bond making a five-membered ring. In the crystal, mol-ecules are connected into centrosymmetric dimers via pairs of N-H⋯N and weak C-H⋯N hydrogen bonds. The crystal structure also features C-H⋯O inter-actions.

No MeSH data available.


Related in: MedlinePlus

The molecular structure of the title compound, showing the atom labeling scheme and 30% probability displacement ellipsoids.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3344604&req=5

Fap1: The molecular structure of the title compound, showing the atom labeling scheme and 30% probability displacement ellipsoids.


N-(4-Bromo-phen-yl)-2-[(1-cyclo-hexyl-meth-yl-1H-1,2,4-triazol-3-yl)sulfanyl]-acetamide.

Wang YP, Yan WL, Guo Q, He YP - Acta Crystallogr Sect E Struct Rep Online (2012)

The molecular structure of the title compound, showing the atom labeling scheme and 30% probability displacement ellipsoids.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3344604&req=5

Fap1: The molecular structure of the title compound, showing the atom labeling scheme and 30% probability displacement ellipsoids.
Bottom Line: In the molecule, there is an N-H⋯S hydrogen bond making a five-membered ring.In the crystal, mol-ecules are connected into centrosymmetric dimers via pairs of N-H⋯N and weak C-H⋯N hydrogen bonds.The crystal structure also features C-H⋯O inter-actions.

View Article: PubMed Central - HTML - PubMed

ABSTRACT
The title compound, C(17)H(21)BrN(4)OS, was synthesized as a potential reverse transcriptase (RT) inhibitor of the human immunodeficiency virus type 1 (HIV-1). In the molecule, there is an N-H⋯S hydrogen bond making a five-membered ring. In the crystal, mol-ecules are connected into centrosymmetric dimers via pairs of N-H⋯N and weak C-H⋯N hydrogen bonds. The crystal structure also features C-H⋯O inter-actions.

No MeSH data available.


Related in: MedlinePlus